{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:52:10Z","timestamp":1777467130590,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":11,"publisher":"Springer New York","isbn-type":[{"value":"9781493989485","type":"print"},{"value":"9781493989492","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:00:00Z","timestamp":1544572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8949-2_7","type":"book-chapter","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T23:14:30Z","timestamp":1544570070000},"page":"89-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Determination of cN1A Autoantibodies by Cell-Based Immunofluorescence Cytochemistry"],"prefix":"10.1007","author":[{"given":"Satoshi","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Tawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"issue":"5","key":"7_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"RC Griggs","year":"1995","unstructured":"Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP (1995) Inclusion body myositis and myopathies. Ann Neurol 38(5):705\u2013713. \nhttps:\/\/doi.org\/10.1002\/ana.410380504","journal-title":"Ann Neurol"},{"issue":"7","key":"7_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","volume":"6","author":"M Needham","year":"2007","unstructured":"Needham M, Mastaglia FL (2007) Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 6(7):620\u2013631. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(07)70171-0","journal-title":"Lancet Neurol"},{"issue":"4","key":"7_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/mus.24562","volume":"52","author":"AD Paltiel","year":"2015","unstructured":"Paltiel AD, Ingvarsson E, Lee DK, Leff RL, Nowak RJ, Petschke KD, Richards-Shubik S, Zhou A, Shubik M, O'Connor KC (2015) Demographic and clinical features of inclusion body myositis in North America. Muscle Nerve 52(4):527\u2013533. \nhttps:\/\/doi.org\/10.1002\/mus.24562","journal-title":"Muscle Nerve"},{"issue":"3","key":"7_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/ana.23840","volume":"73","author":"HB Larman","year":"2013","unstructured":"Larman HB, Salajegheh M, Nazareno R, Lam T, Sauld J, Steen H, Kong SW, Pinkus JL, Amato AA, Elledge SJ, Greenberg SA (2013) Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann Neurol 73(3):408\u2013418. \nhttps:\/\/doi.org\/10.1002\/ana.23840","journal-title":"Ann Neurol"},{"issue":"3","key":"7_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.23822","volume":"73","author":"H Pluk","year":"2013","unstructured":"Pluk H, van Hoeve BJ, van Dooren SH, Stammen-Vogelzangs J, van der Heijden A, Schelhaas HJ, Verbeek MM, Badrising UA, Arnardottir S, Gheorghe K, Lundberg IE, Boelens WC, van Engelen BG, Pruijn GJ (2013) Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis. Ann Neurol 73(3):397\u2013407. \nhttps:\/\/doi.org\/10.1002\/ana.23822","journal-title":"Ann Neurol"},{"issue":"5","key":"7_CR6","doi-asserted-by":"publisher","first-page":"e20266","DOI":"10.1371\/journal.pone.0020266","volume":"6","author":"M Salajegheh","year":"2011","unstructured":"Salajegheh M, Lam T, Greenberg SA (2011) Autoantibodies against a 43 KDa muscle protein in inclusion body myositis. PLoS One 6(5):e20266. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0020266","journal-title":"PLoS One"},{"issue":"1","key":"7_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/acr.22600","volume":"68","author":"TE Lloyd","year":"2016","unstructured":"Lloyd TE, Christopher-Stine L, Pinal-Fernandez I, Tiniakou E, Petri M, Baer A, Danoff SK, Pak K, Casciola-Rosen LA, Mammen AL (2016) Cytosolic 5'-Nucleotidase 1A as a target of circulating autoantibodies in autoimmune diseases. Arthritis Care Res (Hoboken) 68(1):66\u201371. \nhttps:\/\/doi.org\/10.1002\/acr.22600","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"7_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/jnnp-2014-310008","volume":"87","author":"NA Goyal","year":"2016","unstructured":"Goyal NA, Cash TM, Alam U, Enam S, Tierney P, Araujo N, Mozaffar FH, Pestronk A, Mozaffar T (2016) Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement. J Neurol Neurosurg Psychiatry 87(4):373\u2013378. \nhttps:\/\/doi.org\/10.1136\/jnnp-2014-310008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"7_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/mus.24199","volume":"50","author":"SA Greenberg","year":"2014","unstructured":"Greenberg SA (2014) Cytoplasmic 5\u2032-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utility. Muscle Nerve 50(4):488\u2013492. \nhttps:\/\/doi.org\/10.1002\/mus.24199","journal-title":"Muscle Nerve"},{"issue":"4","key":"7_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/annrheumdis-2014-206691","volume":"75","author":"MK Herbert","year":"2016","unstructured":"Herbert MK, Stammen-Vogelzangs J, Verbeek MM, Rietveld A, Lundberg IE, Chinoy H, Lamb JA, Cooper RG, Roberts M, Badrising UA, De Bleecker JL, Machado PM, Hanna MG, Plestilova L, Vencovsky J, van Engelen BG, Pruijn GJ (2016) Disease specificity of autoantibodies to cytosolic 5\u2032-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases. Ann Rheum Dis 75(4):696\u2013701. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2014-206691","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.24919","volume":"81","author":"N Tawara","year":"2017","unstructured":"Tawara N, Yamashita S, Zhang X, Korogi M, Zhang Z, Doki T, Matsuo Y, Nakane S, Maeda Y, Sugie K, Suzuki N, Aoki M, Ando Y (2017) Pathomechanisms of anti-cytosolic 5\u2032-nucleotidase 1A autoantibodies in sporadic inclusion body myositis. Ann Neurol 81(4):512\u2013525. \nhttps:\/\/doi.org\/10.1002\/ana.24919","journal-title":"Ann Neurol"}],"container-title":["Methods in Molecular Biology","Autoantibodies"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8949-2_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T23:15:26Z","timestamp":1544570126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8949-2_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"ISBN":["9781493989485","9781493989492"],"references-count":11,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8949-2_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,12]]}}}